NCT02058173View on ClinicalTrials.gov

"Pharmacoepidemiological Evaluation of Autophagy Inhibition in Treatment of HCV Patients Resistant to Standard Therapy. Pilot Study"

PHASE4CompletedINTERVENTIONAL
Enrollment

10

Participants

Timeline

Start Date

January 31, 2014

Primary Completion Date

June 30, 2014

Study Completion Date

June 30, 2014

Conditions
Hepatitis C Virus
Interventions
DRUG

150 mg/daily chloroquine compare to placebo for 12 week

DRUG

Chloroquine

DRUG

placebo

Trial Locations (1)

Unknown

Health Policy Research Center, Shiraz

All Listed Sponsors
lead

Shiraz University of Medical Sciences

OTHER

NCT02058173 - "Pharmacoepidemiological Evaluation of Autophagy Inhibition in Treatment of HCV Patients Resistant to Standard Therapy. Pilot Study" | Biotech Hunter | Biotech Hunter